A challenge to discover drug candidates using AI has garnered significant attention, with over 2,000 molecule submissions in just three days. The Open Discovery Challenge, hosted by VIDRAFT, has seen Claude take an early lead in the results.

Chinese open models are also performing well, rivaling OpenAI in the challenge. The competition aims to compare the capabilities of different AI models, including OpenAI, Claude, Gemini, and DeepSeek, in discovering potential drug candidates.

Further details about the challenge and its participants are available, providing insight into the performance of various AI models in this context.